Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 3 records, 1 pages
Search For: Age-Related Macular Degeneration (AMD) Therapeutics
Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
Age-Related Macular Degeneration (AMD) Therapeutics
According to our (Global Info Research) latest study, the global Age-Related Macular Degeneration (AMD) Therapeutics market size was valued at USD 7949.4 million in 2023 and is forecast to a readjusted size of USD 11600 million by 2030 with a CAGR of 5.6% during review period.
USD3480.00
Add To Cart
Global Age-Related Macular Degeneration (AMD) Therapeutics Supply, Demand and Key Producers, 2023-2029
19 Jan 2023
Pharma & Healthcare
Age-Related Macular Degeneration (AMD) Therapeutics
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
USD4480.00
Add To Cart
Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
11 Jan 2023
Pharma & Healthcare
Age-Related Macular Degeneration (AMD) Therapeutics
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Age-Related Macular Degeneration (AMD) Therapeutics
Total: 3 records, 1 pages
According to our (Global Info Research) latest study, the global Age-Related Macular Degeneration (AMD) Therapeutics market size was valued at USD 7949.4 million in 2023 and is forecast to a readjusted size of USD 11600 million by 2030 with a CAGR of 5.6% during review period.
USD3480.00
Add To Cart
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
USD4480.00
Add To Cart
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>